257 related articles for article (PubMed ID: 28376898)
21. [Retrospective analysis of the clinical outcomes in 12 recurrent borderline ovarian tumor patients with second fertility-sparing surgery].
Chen R; Zhu T; Yu H; Zhu J; Lu X
Zhonghua Fu Chan Ke Za Zhi; 2014 Apr; 49(4):254-9. PubMed ID: 24969331
[TBL] [Abstract][Full Text] [Related]
22. Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome.
Avril S; Hahn E; Specht K; Hauptmann S; Höss C; Kiechle M; Höfler H; Schmalfeldt B
Gynecol Oncol; 2012 Dec; 127(3):516-24. PubMed ID: 23000388
[TBL] [Abstract][Full Text] [Related]
23. What is the impact of stromal microinvasion on oncologic outcomes in borderline ovarian tumors? A multicenter case-control study.
Boyraz G; Salman MC; Gultekin M; Ozkan NT; Uckan HH; Gungorduk K; Gulseren V; Ayik H; Toptas T; Kuru O; Sozen H; Erturk A; Ozgul N; Meydanlı MM; Sanci M; Turan T; Gungor T; Simsek T; Topuz S; Yuce K
Arch Gynecol Obstet; 2017 Nov; 296(5):979-987. PubMed ID: 28866783
[TBL] [Abstract][Full Text] [Related]
24. Borderline Ovarian Tumors: Fifteen Years' Experience at a Scottish Tertiary Cancer Center.
May J; Skorupskaite K; Congiu M; Ghaoui N; Walker GA; Fegan S; Martin CW; O'Donnell RL
Int J Gynecol Cancer; 2018 Nov; 28(9):1683-1691. PubMed ID: 30365457
[TBL] [Abstract][Full Text] [Related]
25. Fertility preservation in women with borderline ovarian tumors - how does it impact disease outcome? A cohort study.
Helpman L; Yaniv A; Beiner ME; Aviel-Ronen S; Perri T; Ben-Baruch G; Hogen Ben-David L; Jakobson-Setton A; Korach J
Acta Obstet Gynecol Scand; 2017 Nov; 96(11):1300-1306. PubMed ID: 28815550
[TBL] [Abstract][Full Text] [Related]
26. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
Chen RF; Li J; Zhu TT; Yu HL; Lu X
J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
[TBL] [Abstract][Full Text] [Related]
27. Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT study.
Trillsch F; Mahner S; Vettorazzi E; Woelber L; Reuss A; Baumann K; Keyver-Paik MD; Canzler U; Wollschlaeger K; Forner D; Pfisterer J; Schroeder W; Muenstedt K; Richter B; Fotopoulou C; Schmalfeldt B; Burges A; Ewald-Riegler N; de Gregorio N; Hilpert F; Fehm T; Meier W; Hillemanns P; Hanker L; Hasenburg A; Strauss HG; Hellriegel M; Wimberger P; Kommoss S; Kommoss F; Hauptmann S; du Bois A
Br J Cancer; 2015 Feb; 112(4):660-6. PubMed ID: 25562434
[TBL] [Abstract][Full Text] [Related]
28. Unilateral cystectomy and serous histology are associated with relapse in borderline ovarian tumor patients with fertility-sparing surgery: a systematic review and meta-analysis.
Li N; Ming X; Li Z
Arch Gynecol Obstet; 2020 Nov; 302(5):1063-1074. PubMed ID: 32748055
[TBL] [Abstract][Full Text] [Related]
29. Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.
Anfinan N; Sait K; Ghatage P; Nation J; Chu P
Arch Gynecol Obstet; 2011 Sep; 284(3):731-5. PubMed ID: 20963432
[TBL] [Abstract][Full Text] [Related]
30. Ultrasonographic diagnosis and longitudinal follow-up of recurrences after conservative surgery for borderline ovarian tumors.
Franchi D; Boveri S; Radice D; Portuesi R; Zanagnolo V; Colombo N; Testa AC
Am J Obstet Gynecol; 2016 Dec; 215(6):756.e1-756.e9. PubMed ID: 27443811
[TBL] [Abstract][Full Text] [Related]
31. Fertility and prognosis of borderline ovarian tumor after conservative management: Results of the multicentric OPTIBOT study by the GINECO & TMRG group.
Chevrot A; Pouget N; Bats AS; Huchon C; Guyon F; Chopin N; Rousset-Jablonski C; Beurrier F; Lambaudie E; Provansal M; Sabatier R; Heinemann M; Ngo C; Bonsang-Kitzis H; Lecuru F; Bailly E; Ferron G; Cornou C; Lardin E; Leblanc E; Philip CA; Ray-Coquard I; Hequet D
Gynecol Oncol; 2020 Apr; 157(1):29-35. PubMed ID: 32241341
[TBL] [Abstract][Full Text] [Related]
32. [A retrospective study of tumor and fertility outcomes after fertility-sparing surgical treatment of patients with borderline ovarian tumors].
Liu F; Hu DH; Zhang YF; Wang B; Huang K; Wang CY; Xia XY
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3699-3703. PubMed ID: 29325322
[No Abstract] [Full Text] [Related]
33. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Fertility].
Raad J; Rolland L; Grynberg M; Courbiere B; Mathieu d'Argent E
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):330-336. PubMed ID: 32004782
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
Yang ZJ; Wei RJ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
[TBL] [Abstract][Full Text] [Related]
35. Influence of histological subtypes on the risk of an invasive recurrence in a large series of stage I borderline ovarian tumor including 191 conservative treatments.
Uzan C; Nikpayam M; Ribassin-Majed L; Gouy S; Bendifallah S; Cortez A; Rey A; Duvillard P; Darai E; Morice P
Ann Oncol; 2014 Jul; 25(7):1312-1319. PubMed ID: 24713312
[TBL] [Abstract][Full Text] [Related]
36. Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor: an analysis of a series of 42 lymphadenectomies.
Camatte S; Morice P; Atallah D; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Castaigne D
J Am Coll Surg; 2002 Sep; 195(3):332-8. PubMed ID: 12229940
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors and survival of borderline ovarian tumors in Rajavithi Hospital between 1979-2006 A.D.
Sornsukolrat S; Tuipae S
J Med Assoc Thai; 2012 Sep; 95(9):1141-8. PubMed ID: 23140030
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors predicting recurrence in borderline ovarian tumors.
Wu TI; Lee CL; Wu MY; Hsueh S; Huang KG; Yeh CJ; Lai CH
Gynecol Oncol; 2009 Aug; 114(2):237-41. PubMed ID: 19481786
[TBL] [Abstract][Full Text] [Related]
39. Mucinous borderline ovarian tumor versus invasive well-differentiated mucinous ovarian cancer: Difference in characteristics and outcomes.
Matsuo K; Machida H; Mandelbaum RS; Grubbs BH; Roman LD; Sood AK; Gershenson DM
Gynecol Oncol; 2019 May; 153(2):230-237. PubMed ID: 30797590
[TBL] [Abstract][Full Text] [Related]
40. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]